{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:56:17Z","timestamp":1788587777522,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.neuropharm.2014.03.018","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T20:15:13Z","timestamp":1397333713000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats"],"prefix":"10.1016","volume":"83","author":[{"given":"Krystyna","family":"Ossowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Wardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemencja","family":"Berghauzen-Maciejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"G\u0142owacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Pilc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevin H.","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Doller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.03.018_bib1","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1471-4159.2008.05290.x","article-title":"Depression of excitatory transmission at PF-PC synapse by group III metabotropic glutamate receptors is provided exclusively by mGluR4 in the rodent cerebellar cortex","volume":"105","author":"Abitbol","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1471-4159.2011.07611.x","article-title":"Modulation of glutamate release from parallel fibers by mGlu4 and presynaptic GABA(A) receptors","volume":"120","author":"Antflick","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/B:NEUR.0000029648.81071.20","article-title":"Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway","volume":"33","author":"Beitz","year":"2004","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2012.03.022","article-title":"Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia","volume":"66","author":"Bennouar","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib5","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1097\/00001756-199912160-00026","article-title":"Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum","volume":"10","author":"Berthele","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib6","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1096\/fj.09-131789","article-title":"Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism","volume":"23","author":"Beurrier","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9861(19990428)407:1<33::AID-CNE3>3.0.CO;2-G","article-title":"Immunohistochemical localization of sybtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia","volume":"407","author":"Bradley","year":"1999","journal-title":"J.\u00a0Com. Neurol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-8993(80)90491-6","article-title":"The olivocerebellar system. I. Delayed and slow inhibitory effects: an overlooked salient feature of cerebellar climbing fibers","volume":"187","author":"Colin","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0306-4522(01)00591-7","article-title":"Distribution and synaptic localization of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS","volume":"110","author":"Corti","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1471-4159.2009.06036.x","article-title":"Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson\u2019s disease treatment","volume":"109","author":"Cuomo","year":"2009","journal-title":"J.\u00a0Neurochem."},{"issue":"116","key":"10.1016\/j.neuropharm.2014.03.018_bib11","first-page":"1","article-title":"Seeking a unified framework for cerebellar function and dysfunction: from circuit operations to cognition","volume":"6","author":"D\u2019Angelo","year":"2013","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/brain\/awm018","article-title":"Genetics of essential tremor","volume":"130","author":"Deng","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib13","series-title":"655.28\/M10, 40th Annual Society for Neuroscience, San Diego, CA","article-title":"Lu AF21934, a brain penetrant mGlu4 receptor positive allosteric modulator tool compound","author":"Doller","year":"2010"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(96)01148-1","article-title":"Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit","volume":"745","author":"Du","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuroscience.2004.02.020","article-title":"Imaging parallel fiber and climbing fiber responses and their short-term interactions in the mouse cerebellar cortex in\u00a0vivo","volume":"126","author":"Dunbar","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1476-5381.2010.00882.x","article-title":"Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease","volume":"161","author":"Duty","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(95)00795-4","article-title":"Effects of 7-nitroindazole, N6-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions","volume":"299","author":"Eblen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.neuropharm.2011.06.007","article-title":"Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia","volume":"62","author":"Fell","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0270(01)00359-4","article-title":"A\u00a0force-plate actimeter for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor","volume":"107","author":"Fowler","year":"2001","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brainres.2013.08.059","article-title":"A\u00a0partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum","volume":"1537","author":"Go\u0142embiowska","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib21","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1096\/fj.11-195941","article-title":"A\u00a0novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential","volume":"26","author":"Goudet","year":"2012","journal-title":"FASEB"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0306-4522(92)90378-F","article-title":"Localization of AMPA receptors in the hippocampus and cerebellum of the rat using an anti-receptor monoclonal antibody","volume":"50","author":"Hampson","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.physbeh.2005.07.006","article-title":"Effect of harmaline on anxiety-related behavior in mice","volume":"86","author":"Hilber","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2011.05.015","article-title":"The effect of memantine in harmaline-induced tremor and neurodegeneration","volume":"61","author":"Iseri","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s002130100879","article-title":"Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition","volume":"159","author":"Iurlo","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/abbi.1996.9771","article-title":"Inhibition of monoamine oxidase A by beta-carboline derivatives","volume":"337","author":"Kim","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(96)12519-2","article-title":"Presynaptic localization of a metabotropic glutamate receptor mGluR4a in the cerebellar cortex: a light and electron microscope study in the rat","volume":"20","author":"Kinoshita","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00702-009-0254-5","article-title":"Role of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats","volume":"116","author":"Kolasiewicz","year":"2009","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12311-011-0250-9","article-title":"Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats","volume":"10","author":"Kolasiewicz","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2012.08.015","article-title":"6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats","volume":"1477","author":"Kolasiewicz","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0006-8993(71)90174-0","article-title":"Harmaline-induced rhythmic activity of cerebellar and lower brain stem neurons","volume":"32","author":"Lamarre","year":"1971","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/WCO.0b013e3281e66942","article-title":"Update on pathogenesis and treatment of essential tremor","volume":"20","author":"Lorenz","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib33","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1152\/jn.1995.73.6.2568","article-title":"EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive","volume":"73","author":"Milner","year":"1995","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/14734220601016080","article-title":"Rodent models of tremor","volume":"6","author":"Miwa","year":"2007","journal-title":"Cerebellum"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib35","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/00001756-200008030-00010","article-title":"Differential expression of c-Fos following administration of two tremorgenic agents: harmaline and oxotremorine","volume":"11","author":"Miwa","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib36","series-title":"Ethnopharmacologic Search for Psychoactive Drugs","first-page":"385","article-title":"Psychotropic properties of the harmala alkaloids","author":"Naranjo","year":"1967"},{"issue":"8","key":"10.1016\/j.neuropharm.2014.03.018_bib37","doi-asserted-by":"crossref","first-page":"e42650","DOI":"10.1371\/journal.pone.0042650","article-title":"Widespread state-dependent shifts in cerebellar activity in locomoting mice","volume":"7","author":"Ozden","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.05.031","article-title":"Pharmacological characterization of harmaline-induced tremor in mice","volume":"616","author":"Paterson","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib39","series-title":"The Rat Brain","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(95)11469-D","article-title":"Interaction of \u03b2-carbolines with central dopaminergic transmission in mice: structure-activity relationships","volume":"189","author":"Pimpinella","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF01291787","article-title":"Neuropharmacological characterization of local ibogaine effects on dopamine release","volume":"103","author":"Reid","year":"1996","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0014-2999(81)90173-4","article-title":"Benzodiazepine antagonism by harmane and other beta-carbolines in\u00a0vitro and in\u00a0vivo","volume":"70","author":"Rommelspacher","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib43","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1021\/jm070262c","article-title":"Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists","volume":"50","author":"Sibille","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuropharm.2012.05.001","article-title":"Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of mGlu4 receptor","volume":"66","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib45","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/bph.12254","article-title":"The antipsychotic-like effects of mGlu4 receptor positive allosteric modulators in rodents","volume":"169","author":"S\u0142awi\u0144ska","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(00)00930-7","article-title":"Immunohistochemical localization of N-methyl-D-aspartate receptor NR1, NR2A, NR2B and NR2C\/D subunits in the adult mammalian cerebellum","volume":"283","author":"Thompson","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0891-0618(01)00153-3","article-title":"Stimulus-dependent activation of c-Fos in neurons and glia in the rat cerebellum","volume":"23","author":"Tian","year":"2002","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(87)90287-1","article-title":"Benzodiazepine receptors are involved in tabernanthine-induced tremor: in\u00a0vitro and in\u00a0vivo evidence","volume":"140","author":"Trouvin","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib49","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.23-18-07218.2003","article-title":"Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse","volume":"23","author":"Valenti","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002130100882","article-title":"Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine","volume":"158","author":"Wang","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib51","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.neuroscience.2005.05.033","article-title":"Altered glutamate and GABA release within thalamocortical circuitry in metabotropic glutamate receptor 4 knockout mice","volume":"134","author":"Wang","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib52","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1046\/j.1460-9568.1998.00334.x","article-title":"Systemic harmaline blocks associative and motor learning by the actions of the inferior olive","volume":"10","author":"Welsh","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib53","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00213-013-3005-0","article-title":"The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP-2111, involves 5-HT1A signalling","volume":"227","author":"Wiero\u0144ska","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G","article-title":"Animal models of tremor","volume":"14","author":"Wilms","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2014.03.018_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0306-4522(90)90374-D","article-title":"Aspartate-like and glutamate-like immunoreactivities in the inferior olive and climbing fibre system: a light microscopic and semiquantitative electron microscopic study in rat and baboon","volume":"38","author":"Zhang","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.03.018_bib56","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.foodchem.2012.03.024","article-title":"Metabolic pathways of the psychotic-carboline alkaloids, harmaline and harmine, by liquid chromatography\/mass spectrometry and NMR spectroscopy","volume":"134","author":"Zhao","year":"2012","journal-title":"Food Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T13:11:22Z","timestamp":1565356282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":56,"alternative-id":["S0028390814001233"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}